PlasmaGen Biosciences

PlasmaGen Biosciences bags ₹150 cr to scale int'l plasma therapeutics

Bengaluru-based PlasmaGen Biosciences raised ₹150 cr in a minority equity round led by ViNS Bioproducts at a valuation of over ₹1,500 cr to scale international operations

Updated On: 22 Dec 2025 | 2:34 PM IST

PlasmaGen Biosciences hopes for turnover of Rs 640 crore in five years

Awareness of human plasma products and their utility is still nascent

Updated On: 13 Aug 2017 | 11:31 PM IST